Basic Information
RNALocate ID: RLID:01001288
RNA Symbol: hsa-miR-19b-3p
Localization: Mitochondrion
RNA Information
RNA Name: hsa-miR-19b
RNA ID: miRBase:MIMAT0000074
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 21637849
Tissue/Cell Line: Skeletal muscle myoblasts
Method: ISH|qRT-PCR
Description: List of microRNA significantly detected in the mitochondrial mRNA at three increasing mtRNA inputs (1, 5 and 35 uL). Table S3 List of microRNA significantly detected (Cp<35) in the mitochondrial mRNA at the two highest mtRNA inputs (5 and 35 uL). Data are collected from Table 4 and S3.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001283 Cytoplasm Nasopharyngeal carcinoma cells 20498841
RLID:01001284 Cytoplasm Colon cancer cells 20864815
RLID:01001285 Cytoplasm Cell line (HeLa) 21695135
RLID:01001286 Cytoplasm Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001287 Mitochondrion Myotube 27396686
RLID:01001289 Mitochondrion Cell line (HEK-293|HeLa) 22984580
RLID:01001290 Nucleus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001291 Nucleolus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001292 Nucleus GC cell line (MGC-803) 29872807
RLID:01001293 Nucleus Nasopharyngeal carcinoma cells 20498841
RLID:11000724 Exosome Glioblastoma cells 19011622
RLID:11000725 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11000726 Exosome Renal cancer cells 21670082
RLID:11000727 Exosome Brain tissue 23382797
RLID:11000728 Exosome Plasma 23663360
RLID:11000729 Exosome Human mast cell line (HMC-1) 24009880
RLID:11000730 Exosome Human esophageal cancer cell line (EC9706) 25184951
RLID:11000731 Exosome Colon cancer cell line (LIM1863) 25330373
RLID:11000732 Extracellular Vesicle Liposarcoma cell lines (Lipo246|Lipo863|LPS141)|Preadipocytes 28588009
RLID:11000733 Microvesicle Glioblastoma cells 19011622
RLID:11000734 Microvesicle Seminal plasma 23539611
RLID:11000735 Microvesicle Follicular fluid 23666971
RLID:11000736 Microvesicle Cerebrospinal fluid 24797360
RLID-D:11000011 Exosome B lymphoblastoid cells|Breast milk|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue
RLID-D:11000273 Microvesicle Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-19b-3p Diffuse large b cell lymphoma MNDR-E-MI-25628
MNDR hsa-miR-19b-3p Mantle cell lymphoma MNDR-E-MI-25629
MNDR hsa-miR-19b-3p Splenic marginal zone lymphoma MNDR-E-MI-25630
MNDR hsa-miR-19b-3p Multiple sclerosis chronic progressive MNDR-E-MI-25631
MNDR hsa-miR-19b-3p Oral squamous cell carcinoma MNDR-E-MI-25632
MNDR hsa-miR-19b-3p Large cell neuroendocrine cancer MNDR-E-MI-25633
MNDR hsa-miR-19b-3p Medulloblastoma MNDR-E-MI-25634
MNDR hsa-miR-19b-3p Uterine corpus endometrial carcinoma MNDR-E-MI-25635
MNDR hsa-miR-19b-3p Lymphoma MNDR-E-MI-25636
MNDR hsa-miR-19b-3p Lymphoma non-hodgkin MNDR-E-MI-25637
MNDR hsa-miR-19b-3p Estrogen-receptor negative breast cancer MNDR-E-MI-25638
MNDR hsa-miR-19b-3p Progesterone-receptor negative breast cancer MNDR-E-MI-25639
MNDR hsa-miR-19b-3p Her2-receptor positive breast cancer MNDR-E-MI-25640
MNDR hsa-miR-19b-3p Niemann-pick disease type c MNDR-E-MI-25641
MNDR hsa-miR-19b-3p Prostate cancer MNDR-E-MI-25642
MNDR hsa-miR-19b-3p Gastric cancer MNDR-E-MI-25643
MNDR hsa-miR-19b-3p Gastric lymphoma MNDR-E-MI-25644
MNDR hsa-miR-19b-3p Alzheimer disease MNDR-E-MI-25645
MNDR hsa-miR-19b-3p Encephalitis japanese MNDR-E-MI-25646
MNDR hsa-miR-19b-3p Intracranial aneurysm MNDR-E-MI-25647
MNDR hsa-miR-19b-3p Bladder cancer MNDR-E-MI-25648
MNDR hsa-miR-19b-3p Sarcoma MNDR-E-MI-25649
MNDR hsa-miR-19b-3p Dysautonomia familial MNDR-E-MI-25650
MNDR hsa-miR-19b-3p Head and neck cancer MNDR-E-MI-25651
MNDR hsa-miR-19b-3p Huntington disease MNDR-E-MI-25652
MNDR hsa-miR-19b-3p Chorea MNDR-E-MI-25653
MNDR hsa-miR-19b-3p Cardiovascular disease MNDR-E-MI-25654
MNDR hsa-miR-19b-3p Carotid stenosis MNDR-E-MI-25655
MNDR hsa-miR-19b-3p Moyamoya disease MNDR-E-MI-25656
MNDR hsa-miR-19b-3p Lung cancer MNDR-E-MI-25657
MNDR hsa-miR-19b-3p Fragile x syndrome MNDR-E-MI-25658
MNDR hsa-miR-19b-3p Parkinson disease MNDR-E-MI-25659
MNDR hsa-miR-19b-3p Machado-joseph disease MNDR-E-MI-25660
MNDR hsa-miR-19b-3p Niemann-pick disease MNDR-E-MI-25661
MNDR hsa-miR-19b-3p Basal-like breast cancer MNDR-E-MI-25662
MNDR hsa-miR-19b-3p Squamous cell carcinoma MNDR-E-MI-25663
MNDR hsa-miR-19b-3p Thyroid cancer MNDR-E-MI-25664
MNDR hsa-miR-19b-3p Pancreatic cancer MNDR-E-MI-25665
MNDR hsa-miR-19b-3p Malignant melanoma MNDR-E-MI-25666
MNDR hsa-miR-19b-3p Atherosclerosis MNDR-E-MI-25667
MNDR hsa-miR-19b-3p Rectum adenocarcinoma MNDR-E-MI-25668
MNDR hsa-miR-19b-3p Nephroblastoma MNDR-E-MI-25669
MNDR hsa-miR-19b-3p Colon cancer MNDR-E-MI-25670
MNDR hsa-miR-19b-3p Ischemic attack transient MNDR-E-MI-25671
MNDR hsa-miR-19b-3p Colon adenocarcinoma MNDR-E-MI-25672
MNDR hsa-miR-19b-3p Multiple sclerosis relapsing-remitting MNDR-E-MI-25673
MNDR hsa-miR-19b-3p Familial ovarian cancer MNDR-E-MI-25674
MNDR hsa-miR-19b-3p Basal cell carcinoma MNDR-E-MI-25675
MNDR hsa-miR-19b-3p Prostate adenocarcinoma MNDR-E-MI-25676
MNDR hsa-miR-19b-3p Kidney cancer MNDR-E-MI-25677
MNDR hsa-miR-19b-3p Thyroid adenomas MNDR-E-MI-25678
MNDR hsa-miR-19b-3p Carcinoma ductal breast MNDR-E-MI-25679
MNDR hsa-miR-19b-3p Glioblastoma MNDR-E-MI-25680
MNDR hsa-miR-19b-3p Astrocytoma MNDR-E-MI-25681
MNDR hsa-miR-19b-3p Glioma MNDR-E-MI-25682
MNDR hsa-miR-19b-3p Chronic obstructive pulmonary disease MNDR-E-MI-25683
MNDR hsa-miR-19b-3p Central nervous system lymphoma MNDR-E-MI-25684
MNDR hsa-miR-19b-3p Amyotrophic lateral sclerosis MNDR-E-MI-25685
MNDR hsa-miR-19b-3p Osteosarcoma MNDR-E-MI-25686
MNDR hsa-miR-19b-3p Liposarcoma MNDR-E-MI-25687
MNDR hsa-miR-19b-3p Coronary artery disease MNDR-E-MI-25688
MNDR hsa-miR-19b-3p Meningioma MNDR-E-MI-25689
MNDR hsa-miR-19b-3p Liver cancer MNDR-E-MI-25690
MNDR hsa-miR-19b-3p Cervical adenocarcinoma MNDR-E-MI-25691
MNDR hsa-miR-19b-3p Gastric adenocarcinoma MNDR-E-MI-25692
MNDR hsa-miR-19b-3p Cervical squamous cell carcinoma MNDR-E-MI-25693
MNDR hsa-miR-19b-3p Lung squamous cell carcinoma MNDR-E-MI-25694
MNDR hsa-miR-19b-3p Carcinoma lung non-small-cell MNDR-E-MI-25695
MNDR hsa-miR-19b-3p Lung adenocarcinoma MNDR-E-MI-25696
MNDR hsa-miR-19b-3p Thyroid carcinoma MNDR-E-MI-25697
MNDR hsa-miR-19b-3p Bladder urothelial carcinoma MNDR-E-MI-25698
MNDR hsa-miR-19b-3p Cervical cancer MNDR-E-MI-25699
MNDR hsa-miR-19b-3p Myasthenia gravis autoimmune experimental MNDR-E-MI-25700
MNDR hsa-miR-19b-3p Carcinoma renal cell MNDR-E-MI-25701
MNDR hsa-miR-19b-3p Kidney renal papillary cell carcinoma MNDR-E-MI-25702
MNDR hsa-miR-19b-3p Renal clear cell carcinoma MNDR-E-MI-25703
MNDR hsa-miR-19b-3p Biliary tract cancer MNDR-E-MI-25704
MNDR hsa-miR-19b-3p Cholangiocarcinoma MNDR-E-MI-25705
MNDR hsa-miR-19b-3p Esophageal cancer MNDR-E-MI-25706
MNDR hsa-miR-19b-3p Lung small cell carcinoma MNDR-E-MI-25707
MNDR hsa-miR-19b-3p Head and neck squamous cell carcinoma MNDR-E-MI-25708
MNDR hsa-miR-19b-3p Encephalomyelitis MNDR-E-MI-25709
MNDR hsa-miR-19b-3p Breast invasive carcinoma MNDR-E-MI-25710
MNDR hsa-miR-19b-3p Hepatocellular carcinoma MNDR-E-MI-25711
MNDR hsa-miR-19b-3p Familiar ovarian carcinoma MNDR-E-MI-25712
MNDR hsa-miR-19b-3p B-cell lymphoma MNDR-E-MI-25713
MNDR hsa-miR-19b-3p Rheumatoid arthritis MNDR-E-MI-25714
MNDR hsa-miR-19b-3p T-cell leukemia MNDR-E-MI-25715
MNDR hsa-miR-19b-3p Cervical carcinoma MNDR-E-MI-25716
MNDR hsa-miR-19b-3p Retinoblastoma MNDR-E-MI-25717
MNDR hsa-miR-19b-3p Neuroblastoma MNDR-E-MI-25718
MNDR hsa-miR-19b-3p Hodgkin lymphoma MNDR-E-MI-25719
MNDR hsa-miR-19b-3p Burkitt lymphoma MNDR-E-MI-25720
MNDR hsa-miR-19b-3p Lymphosarcoma MNDR-E-MI-25721
MNDR hsa-miR-19b-3p Crohn disease MNDR-E-MI-25722
MNDR hsa-miR-19b-3p Intermediate coronary syndrome MNDR-E-MI-25723
MNDR hsa-miR-19b-3p Tonsil cancer MNDR-E-MI-25724
MNDR hsa-miR-19b-3p Acute myelogenous leukemia MNDR-E-MI-25725
MNDR hsa-miR-19b-3p Colorectal cancer MNDR-E-MI-25726
MNDR hsa-miR-19b-3p Nasopharyngeal carcinoma MNDR-E-MI-25727
MNDR hsa-miR-19b-3p Nasopharynx carcinoma MNDR-E-MI-25728
MNDR hsa-miR-19b-3p Multiple myeloma MNDR-E-MI-25729
MNDR hsa-miR-19b-3p Carcinoid tumors intestinal MNDR-E-MI-25730
MNDR hsa-miR-19b-3p Esophageal squamous cell carcinoma MNDR-E-MI-25731
MNDR hsa-miR-19b-3p Uterine cervical neoplasms MNDR-E-MI-25732
MNDR hsa-miR-19b-3p Ependymoma MNDR-E-MI-25733
MNDR hsa-miR-19b-3p Nasopharyngeal cancer MNDR-E-MI-25734
MNDR hsa-miR-19b-3p Prostatic neoplasms MNDR-E-MI-25735
MNDR hsa-miR-19b-3p Stroke lacunar MNDR-E-MI-25736
MNDR hsa-miR-19b-3p Duke A MNDR-E-MI-25737
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ABCB1 Homo sapiens RR00022778
TOP